“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.
The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.
A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.
Publications found:
185,782
Sort by:
Global GP681 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global GP681 market size is expected to reach $ 195 million by 2032, rising at a market growth of 7.9% CAGR during the forecast period (2026-2032). GP681 is a novel oral antiviral drug targeting i...
June 2026
92 pages
Global IMP4279 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global IMP4279 market size is expected to reach $ 50.90 million by 2032, rising at a market growth of 8.7% CAGR during the forecast period (2026-2032). IMP4279 is a novel DNA damage response pathw...
June 2026
93 pages
Global SHR0302 Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global SHR0302 market size is expected to reach $ 1234 million by 2032, rising at a market growth of 16.9% CAGR during the forecast period (2026-2032). SHR0302 (generic name: Ivarmacitinib) is a h...
June 2026
88 pages
